Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04198987 · ClinicalTrials.gov registry record
Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 20
- Enrollment target
NCT04198987: Completed study, sponsored by Mayo Clinic.
NCT04198987 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04198987 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).
Primary Outcome
To assess the effects of oral monosaccharide supplementation for each participant, changes in participant growth parameters, as well as blood sugar levels, coagulation parameters, liver function, and other measures of organ system function (as appropriate for the specific type of CDG) will be correlated with biomarkers derived from participant blood and urine samples obtained at key time points and then compared to standard normative ranges of data for each measure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-06 |
| Est. Completion | 2025-06-11 |
What the finished NCT04198987 record still lists
NCT04198987 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04198987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04198987 about?
NCT04198987 is a clinical study titled "Dietary Monosaccharide Supplementation in Patients With Congenital Disorders of Glycosylation". Researchers are trying to assess whether the use of simple sugars given as a daily dietary supplement can improve the health of children with congenital disorders of glycosylation (CDG).
What is the current status of trial NCT04198987?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-12-06. Estimated completion is 2025-06-11.
Who is sponsoring clinical trial NCT04198987?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI